Physician profile
Waleed Sultan
NPI 1760128409
$1,531.65
in general payments reported to CMS, 2019-2025
12 companies · $1,180 in 2025
The $1,180 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $33.90 · 2023: $146 · 2024: $171 · 2025: $1,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824 · Travel and Lodging: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.79 |
| Travel and Lodging | $673.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $975.29 | 2025 | Senza |
| Abbott Laboratories | $131.69 | 2024 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.02 | 2025 | Relistor, Aldara |
| Alexion Pharmaceuticals, INC. | $113.40 | 2023 | Ultomiris |
| Inari Medical, INC. | $39.50 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lilly USA, LLC | $35.52 | 2022-2023 | Mounjaro |
| Pfizer INC. | $26.62 | 2025 | |
| Abbvie INC. | $23.49 | 2025 | |
| Insulet Corporation | $23.05 | 2025 | Omnipod |
| Ibsa Pharma INC. | $17.82 | 2025 | Licart, Tirosint, Flector |
| Exact Sciences Corporation | $16.32 | 2023 | Cologuard Collection Kit |
| Masimo Corporation | $14.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waleed Sultan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.